LANSING, Mich., Dec. 21, 2023 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Thursday, January 11, 2024.
John Adent, Neogen's President and Chief Executive Officer, will present at 9:00 a.m. Pacific Time.
To access the webcast and presentation materials, please visit the Events & Presentations section of the Neogen Investor Relations website at neogen.com/investor-relations/events-presentations and click on the event webcast link.
About Neogen
Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.
Contact
Bill Waelke — VP, IR & Treasury
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$5.71 |
Daily Change: | 0.08 1.42 |
Daily Volume: | 1,631,037 |
Market Cap: | US$1.240B |
May 13, 2025 January 21, 2025 January 10, 2025 December 17, 2024 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load